Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
60,026,563
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
870,129
-
Shares change
-
+11,713
-
Total reported value, excl. options
-
$6,277,000
-
Value change
-
+$82,000
-
Number of buys
-
2
-
Number of sells
-
-2
-
Price
-
$7.18
Significant Holders of Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) as of Q4 2014
7 filings reported holding ALDX - Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q4 2014.
Aldeyra Therapeutics, Inc. - Common Stock, par value $0.001 per share (ALDX) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 870,129 shares
of 60,026,563 outstanding shares and own 1.4% of the company stock.
Largest 7 shareholders include FMR LLC (834,811 shares), GEODE CAPITAL MANAGEMENT, LLC (22,558 shares), Spark Investment Management LLC (11,200 shares), MORGAN STANLEY (1,291 shares), BlackRock Investment Management, LLC (269 shares), Tower Research Capital LLC (TRC) (0 shares), and MANUFACTURERS LIFE INSURANCE COMPANY, THE (0 shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.